SCHEMBL2247734

SCHEMBL2247734

CC(Cc1c(F)c(F)c(F)c(F)c1F)C[C@@H](C(=O)O)[C@@H]1OC(C)(C)OC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1610132 0.81 L3MBTL1 (0.43)
SCHEMBL3872212 0.81 L3MBTL1 (0.43)
SCHEMBL1609861 0.81 L3MBTL1 (0.43)
SCHEMBL2247539 0.81 L3MBTL1 (0.43)
SCHEMBL18401160 0.74 L3MBTL1 (0.34)
SCHEMBL2245759 0.72 L3MBTL1 (0.32)
SCHEMBL14068110 0.72 L3MBTL1 (0.32)
SCHEMBL1610462 0.72 L3MBTL1 (0.32)
SCHEMBL1609717 0.72 L3MBTL1 (0.32)
SCHEMBL3873093 0.70 CA2 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110263628-A1 N-HYDROXYAMIDE DERIVATIVES AND USE THEREOF APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2011-10-27 US disclosed
US-8008302-B2 ((2S,3S) N,2-dihydroxy-5-methyl-3-{[4-(2-pyridinyl)-1-piperazinyl]carbonyl}hexanamide; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, stroke, cancer, pre-term labor, endometriosis MERCK SERONO SA (CH) 2011-08-30 US disclosed